Want to see IN:SHILPAMED full AI Analyst Report?
Shilpa Medicare Limited (SHILPAMED) Ratios
Shilpa Medicare Limited Ratios
IN:SHILPAMED's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:SHILPAMED's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.31 | 1.46 | 1.26 | 0.98 | 1.45 |
| Quick Ratio | 0.88 | 0.95 | 0.77 | 0.57 | 0.87 |
| Cash Ratio | 0.05 | 0.04 | 0.04 | 0.03 | 0.06 |
| Solvency Ratio | 0.33 | 0.20 | 0.11 | 0.06 | 0.13 |
| Operating Cash Flow Ratio | 0.35 | 0.20 | 0.20 | 0.23 | 0.17 |
| Short-Term Operating Cash Flow Coverage | 0.62 | 0.37 | 0.36 | 0.35 | 0.32 |
| Net Current Asset Value | $ -46.40M | $ 386.66M | $ -4.16B | $ -3.60B | $ -1.77B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.18 | 0.18 | 0.30 | 0.27 | 0.24 |
| Debt-to-Equity Ratio | 0.25 | 0.25 | 0.52 | 0.45 | 0.37 |
| Debt-to-Capital Ratio | 0.20 | 0.20 | 0.34 | 0.31 | 0.27 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.09 | 0.24 | 0.14 | 0.16 |
| Financial Leverage Ratio | 1.43 | 1.40 | 1.71 | 1.63 | 1.58 |
| Debt Service Coverage Ratio | 0.72 | 0.62 | 0.48 | 0.21 | 0.49 |
| Interest Coverage Ratio | 5.36 | 2.70 | 4.10 | -0.16 | 3.07 |
| Debt to Market Cap | 0.10 | 0.09 | 0.22 | 0.40 | 0.20 |
| Interest Debt Per Share | 36.74 | 34.06 | 59.25 | 49.34 | 43.34 |
| Net Debt to EBITDA | 1.42 | 1.81 | 3.69 | 6.84 | 2.91 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.54% | 68.10% | 61.54% | 12.88% | 66.31% |
| EBIT Margin | 20.47% | 15.38% | 11.97% | 1.72% | 12.56% |
| EBITDA Margin | 28.25% | 24.16% | 21.33% | 10.87% | 19.56% |
| Operating Profit Margin | 20.47% | 15.86% | 32.62% | -0.93% | 11.04% |
| Pretax Profit Margin | 19.19% | 9.51% | 4.71% | -3.67% | 8.97% |
| Net Profit Margin | 15.81% | 6.09% | 2.76% | -3.12% | 5.32% |
| Continuous Operations Profit Margin | 15.81% | 6.09% | 2.77% | -2.97% | 5.31% |
| Net Income Per EBT | 82.40% | 64.00% | 58.66% | 84.99% | 59.32% |
| EBT Per EBIT | 93.75% | 59.95% | 14.45% | 396.50% | 81.27% |
| Return on Assets (ROA) | 6.57% | 2.36% | 1.03% | -1.12% | 2.11% |
| Return on Equity (ROE) | 9.39% | 3.30% | 1.76% | -1.82% | 3.33% |
| Return on Capital Employed (ROCE) | 11.02% | 7.74% | 15.67% | -0.46% | 5.56% |
| Return on Invested Capital (ROIC) | 7.79% | 4.37% | 7.97% | -0.30% | 2.88% |
| Return on Tangible Assets | 8.08% | 2.85% | 1.23% | -1.35% | 2.50% |
| Earnings Yield | 3.57% | 1.22% | 0.74% | -1.64% | 1.82% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.97 | 2.92 | 2.94 | 3.22 | 2.51 |
| Payables Turnover | 6.42 | 4.30 | 2.54 | 6.37 | 2.63 |
| Inventory Turnover | 2.49 | 1.18 | 1.29 | 2.84 | 1.08 |
| Fixed Asset Turnover | 0.86 | 0.77 | 0.70 | 0.68 | 0.76 |
| Asset Turnover | 0.42 | 0.39 | 0.37 | 0.36 | 0.40 |
| Working Capital Turnover Ratio | 5.37 | 5.20 | 13.68 | 8.00 | 3.97 |
| Cash Conversion Cycle | 212.55 | 349.70 | 264.08 | 184.53 | 344.36 |
| Days of Sales Outstanding | 123.06 | 125.08 | 124.10 | 113.46 | 145.57 |
| Days of Inventory Outstanding | 146.31 | 309.46 | 283.86 | 128.41 | 337.58 |
| Days of Payables Outstanding | 56.83 | 84.84 | 143.87 | 57.33 | 138.78 |
| Operating Cycle | 269.38 | 434.54 | 407.95 | 241.87 | 483.14 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 15.09 | 6.79 | 7.79 | 10.36 | 6.29 |
| Free Cash Flow Per Share | -3.85 | -5.72 | -2.83 | -2.69 | -13.57 |
| Dividend Paid and CapEx Coverage Ratio | 0.78 | 0.54 | 0.73 | 0.76 | 0.31 |
| Capital Expenditure Coverage Ratio | 0.80 | 0.54 | 0.73 | 0.79 | 0.32 |
| Operating Cash Flow Coverage Ratio | 0.45 | 0.22 | 0.14 | 0.23 | 0.15 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.10 | 0.12 | 0.17 | 0.09 |
| Free Cash Flow Yield | -1.10% | -1.74% | -1.15% | -2.35% | -6.81% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 28.05 | 81.75 | 134.85 | -61.06 | 54.85 |
| Price-to-Sales (P/S) Ratio | 4.43 | 4.98 | 3.73 | 1.90 | 2.92 |
| Price-to-Book (P/B) Ratio | 2.63 | 2.70 | 2.38 | 1.11 | 1.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -90.51 | -57.43 | -87.32 | -42.50 | -14.68 |
| Price-to-Operating Cash Flow Ratio | 23.12 | 48.42 | 31.76 | 11.04 | 31.65 |
| Price-to-Earnings Growth (PEG) Ratio | 0.13 | 0.69 | -0.68 | 0.40 | -0.91 |
| Enterprise Value Multiple | 17.12 | 22.40 | 21.17 | 24.35 | 17.83 |
| Enterprise Value | 74.43B | 69.63B | 52.05B | 27.63B | 39.77B |
| EV to EBITDA | 17.12 | 22.40 | 21.17 | 24.35 | 17.83 |
| EV to Sales | 4.84 | 5.41 | 4.51 | 2.65 | 3.49 |
| EV to Free Cash Flow | -98.72 | -62.47 | -105.75 | -59.11 | -17.54 |
| EV to Operating Cash Flow | 25.21 | 52.67 | 38.46 | 15.36 | 37.83 |
| Tangible Book Value Per Share | 96.94 | 92.37 | 74.41 | 74.20 | 81.79 |
| Shareholders’ Equity Per Share | 132.47 | 121.80 | 104.13 | 102.72 | 109.04 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.18 | 0.36 | 0.41 | 0.19 | 0.41 |
| Revenue Per Share | 78.67 | 66.05 | 66.38 | 60.11 | 68.22 |
| Net Income Per Share | 12.44 | 4.02 | 1.84 | -1.87 | 3.63 |
| Tax Burden | 0.82 | 0.64 | 0.59 | 0.85 | 0.59 |
| Interest Burden | 0.94 | 0.62 | 0.39 | -2.13 | 0.71 |
| Research & Development to Revenue | 0.00 | 0.04 | 0.03 | 0.05 | 0.05 |
| SG&A to Revenue | 0.20 | 0.21 | 0.26 | 0.03 | 0.05 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.21 | 1.08 | 4.25 | -4.70 | 1.03 |
Currency in INR
